Publications by authors named "Victoria Peek"

Claim this Profile
A
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin Molecules.
Nichole A Reynolds, Yan Q Chen, Richard E Higgs, Boris Calderon, Jeff W Cramer, Victoria L Peek

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Reactive Polyclonal Antibodies Raised Against GalNAc-Conjugated siRNA Recognize Mostly the GalNAc Moiety.
Kimberly K Ballman, Victoria L Peek, John H Sloan, Jingling Li, Robert J Konrad

AAPS J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A competitive ligand binding assay for detection of neutralizing antibodies against an insulin analog.
Victoria L Peek, Deven M Lemen, Robert J Konrad, Yi Wen

J Immunol Methods· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping.
S Betty Yan, Suzane L Um, Victoria L Peek, Jennifer R Stephens, Wei Zeng

Invest New Drugs· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors.
Bruce W Konicek, Andrew R Capen, Kelly M Credille, Philip J Ebert, Beverly L Falcon, Victoria L Peek

Oncotarget· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
Ravi Salgia, R Waide Weaver, Michael McCleod, John R Stille, S Betty Yan, Victoria L Peek

Invest New Drugs· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth.
Ling Liu, Wei Zeng, Mark A Wortinger, S Betty Yan, Paul Cornwell, Victoria L Peek

Clin Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor growth and metastasis in non-small cell lung cancer by LY2801653, an inhibitor of several oncokinases, including MET.
Wenjuan Wu, Chen Bi, Kelly M Credille, Jason R Manro, Victoria L Peek

Clin Cancer Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.
S Betty Yan, Victoria L Peek, Rose Ajamie, Sean G Buchanan, Jeremy R Graff

Invest New Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
William L Perry, Robert L Shepard, Janardhan Sampath, Benjamin Yaden, William W Chin, Victoria L Peek

Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells.
Sheng-Bin Peng, Victoria Peek, Yan Zhai, Donald C Paul, Qinyuan Lou

Mol Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis